Hard Cervical Collar Use Following Posterior Cervical Fusion
for Spinal Stenosis Cervical
2 locations in Washington D.C.
Sponsor: Georgetown University
Sex: All·Age: 18+
Code: NCT07789288·Recruiting·Listed Aug 27, 2026
Clinical Trials at MedStar Washington Hospital Center
As of September 2026, 89 paid clinical trials are recruiting at MedStar Washington Hospital Center in Washington D.C., District of Columbia. Active studies at this site cover conditions such as Breast Cancer, Sickle Cell Disease and Stroke. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Washington D.C.
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
90 clinical trials at MedStar Washington Hospital Center
·Clear filters· Get a weekly email when new trials open in Washington D.C., DC.
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
for Ventricular Arrythmia
Sites in Washington D.C. +26 more locations
Sponsor: AtaCor Medical, Inc.
Sex: All·Age: 18+
Code: NCT07324031·Recruiting·Listed Jan 2026
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
for Carcinoma, Transitional Cell
Sites in Washington D.C. +63 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07218380·Phase 3·Recruiting·Listed Oct 2025
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for Breast Neoplasms
Sites in Washington D.C. +124 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Washington D.C. +171 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
Sites in Washington D.C. +142 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Washington D.C. +82 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Washington D.C. +123 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sites in Washington D.C. +54 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for Endometrial Cancer
Sites in Washington D.C. +45 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Female·Age: 18+
Code: NCT06952504·Phase 3·Recruiting·Listed May 2025
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Washington D.C. +2368 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
for Hypertension
Sites in Washington D.C. +55 more locations
Sponsor: Orchestra BioMed, Inc
Sex: All·Age: 18+
Code: NCT06059638·Recruiting·Listed Sep 2023
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
for Obstructive Hypertrophic Cardiomyopathy
Drug: Mavacamten
Sites in Washington D.C. +47 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05489705·Recruiting·Listed Aug 2022
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for Mitral Valve Regurgitation
Sites in Washington D.C. +66 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 18+
Code: NCT03242642·Recruiting·Listed Aug 2017
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for Breast Cancer
Sites in Washington D.C. +101 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for Advanced Melanoma
Drug: Nivolumab
Sites in Washington D.C. +43 more locations
Sponsor: Replimune, Inc.
Sex: All·Age: 12+
Code: NCT06264180·Phase 3·Recruiting·Listed Feb 2024
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for Relapsing Multiple Sclerosis
Drug: Remibrutinib
Sites in Washington D.C. +42 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 40 - 70
Code: NCT06846281·Phase 3·Recruiting·Listed Feb 2025
SELUTION 4 De Novo Small Vessel IDE Trial
for Coronary Artery Disease
Sites in Washington D.C. +63 more locations
Sponsor: M.A. Med Alliance S.A.
Sex: All·Age: 18+
Code: NCT05946629·Recruiting·Listed Jul 2023
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for Abdominal Aortic Aneurysm
Sites in Washington D.C. +27 more locations
Sponsor: Medtronic Cardiovascular
Sex: All·Age: 20+
Code: NCT05378347·Recruiting·Listed May 2022
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
for Acute Respiratory Distress Syndrome (ARDS)
Sites in Washington D.C. +39 more locations
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06703073·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for Acute Respiratory Distress Syndrome (ARDS)
Drug: Bevacizumab
Sites in Washington D.C. +39 more locations
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701656·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for Acute Respiratory Distress Syndrome (ARDS)
Drug: Cohort B: paridiprubart
Sites in Washington D.C. +39 more locations
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701669·Phase 2·Recruiting·Listed Nov 2024
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
for Acute Respiratory Distress Syndrome (ARDS)
Sites in Washington D.C. +39 more locations
Sponsor: PPD Development, LP
Sex: All·Age: 18+
Code: NCT06701682·Phase 2·Recruiting·Listed Nov 2024
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for Aortic Regurgitation
Sites in Washington D.C. +28 more locations
Sponsor: JenaValve Technology, Inc.
Sex: All·Age: All ages
Code: NCT06608823·Recruiting·Listed Sep 2024
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
Sites in Washington D.C. +54 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
for Pneumonia
Sites in Washington D.C. +38 more locations
Sponsor: Pfizer
Sex: All·Age: 65+
Code: NCT05452941·Recruiting·Listed Jul 2022
Nectero EAST System Clinical Study
for Abdominal Aortic Aneurysm
Sites in Washington D.C. +32 more locations
Sponsor: Nectero Medical, Inc.
Sex: All·Age: 21 - 85
Code: NCT06001918·Phase 2, Phase 3·Recruiting·Listed Aug 2023
Prevail Global Study
for Coronary Artery Disease
Sites in Washington D.C. +50 more locations
Sponsor: Medtronic Vascular
Sex: All·Age: 18+
Code: NCT06535854·Recruiting·Listed Aug 2024
Zenith® Fenestrated+ Clinical Study
for Aortic Aneurysm, Abdominal
Sites in Washington D.C. +29 more locations
Sponsor: Cook Research Incorporated
Sex: All·Age: 18+
Code: NCT04875429·Recruiting·Listed May 2021
FORWARD CAD IDE Study
for Coronary Arterial Disease (CAD)
Sites in Washington D.C. +27 more locations
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT06662500·Recruiting·Listed Oct 2024
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for Advanced Gastrointestinal Stromal Tumors
Sites in Washington D.C. +7 more locations
Sponsor: Cogent Biosciences, Inc.
Sex: All·Age: 18+
Code: NCT05208047·Phase 3·Recruiting·Listed Jan 2022
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for AAA
Sites in Washington D.C. +24 more locations
Sponsor: Endologix
Sex: All·Age: 21+
Code: NCT05064540·Recruiting·Listed Oct 2021
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for Symptomatic Genetic Dilated Cardiomyopathy
Sites in Washington D.C. +27 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 18+
Code: NCT07210723·Phase 2, Phase 3·Recruiting·Listed Oct 2025
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for Aortic Arch Dissection
Sites in Washington D.C. +15 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT07166133·Recruiting·Listed Sep 2025
The ArtixASCEND Study
for Acute Lower Limb Arterial Occlusion
Sites in Washington D.C. +19 more locations
Sponsor: Inari Medical
Sex: All·Age: 18+
Code: NCT07135895·Recruiting·Listed Aug 2025
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
for Aortic Aneurysm
Sites in Washington D.C. +14 more locations
Sponsor: Vascutek Ltd.
Sex: All·Age: 18+
Code: NCT07078383·Recruiting·Listed Jul 2025
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for Generalized Myasthenia Gravis
Drug: Remibrutinib
Sites in Washington D.C. +23 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT06744920·Phase 3·Recruiting·Listed Dec 2024
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)
for Venous Leg Ulcer (VLU)
Sites in Washington D.C. +16 more locations
Sponsor: MediWound Ltd
Sex: All·Age: 18+
Code: NCT06568627·Phase 3·Recruiting·Listed Aug 2024
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
for Chronic Inflammatory Demyelinating Polyneuropathy
Sites in Washington D.C. +13 more locations
Sponsor: argenx
Sex: All·Age: 18+
Code: NCT06920004·Phase 3·Recruiting·Listed Apr 2025
STOP AF First Post-Approval Study
for Paroxysmal Atrial Fibrillation
Sites in Washington D.C. +9 more locations
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All·Age: 18+
Code: NCT05227053·Recruiting·Listed Feb 2022
Terumo Aortic Global Endovascular Registry
for Abdominal Aortic Aneurysm
Sites in Washington D.C. +16 more locations
Sponsor: Vascutek Ltd.
Sex: All·Age: 18+
Code: NCT04246463·Recruiting·Listed Jan 2020
Common conditions studied in Washington D.C.
- Breast Cancer (15 active studies)
- Sickle Cell Disease (12 active studies)
- Stroke (11 active studies)
- Heart Failure (9 active studies)
- Obesity (9 active studies)
- Prostate Cancer (9 active studies)
Leading research sponsors in Washington D.C.
- Children's National Research Institute
- Georgetown University
- National Cancer Institute (NCI)
- George Washington University
- Medstar Health Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Washington D.C.?
There are approximately 840 recruiting clinical trials in Washington D.C., District of Columbia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Washington D.C. pay participants?
Most recruiting trials in Washington D.C. compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Washington D.C.?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Washington D.C.?
The most common conditions under active study in Washington D.C. include Breast Cancer (15), Sickle Cell Disease (12), Stroke (11), Heart Failure (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Washington D.C.?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Washington D.C. on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Washington D.C.?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Washington D.C.?
Recruiting research sites in Washington D.C. include MedStar Washington Hospital Center, Children's National Medical Center, Children's National Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Washington D.C. right now?
The largest active categories in Washington D.C. are Cancer & tumors (290), Neurology & pain (64), Cardiovascular (51). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.